Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery. Powley IR, Patel M, Miles G, Pringle H, et al. Br J Cancer 2020;122:735-744.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Powley IR, Patel M, Miles G, Pringle H, et al. Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery. Br J Cancer 2020;122:735-744.
PMID: 31894140